Drugs / Gypenosides
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02976766 | Feb 2017 → Jul 2018 | optic neuritis | First Affiliated Hospital of Guangxi Medical University | Terminated | Missed primary Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gypenosides | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02976766 ↗ |
| Route | Oral | “Participants received adjunctive oral gypenosides” NCT02976766 ↗ |